Phio Pharmaceuticals Presents New Data for Targeting of

--Preclinical data shows melanoma cells treated with PH-894 makes them more recognizable to immune cells, increasing potential for elimination ...

Related Keywords

Boston ,Massachusetts ,United States ,Michael Adams ,International Conference On Molecular ,Nasdaq ,Phio Pharmaceuticals Corp ,Molecular Targets ,Cancer Therapeuticsin Boston ,Cancer Therapeutics ,Private Securities Litigation Reform Act ,Annual Report ,Quarterly Reports ,View Media ,Nasdaq Phio ,Immunooncology ,Ntasyl ,Unai ,Ohio ,